Old West Investment Management, LLC Akebia Therapeutics, Inc. Transaction History

Old West Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.39 - $13.08 $119,676 - $654,967	-50,074 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$6.67 - $13.58 $1,093 - $2,227	-164 Reduced 0.33%	50,074 $680,000
Q1 2020 May 15, 2020	SELL	$4.1 - $10.24 $22,496 - $56,186	-5,487 Reduced 9.85%	50,238 $380,000
Q4 2019 Feb 11, 2020	SELL	$3.16 - $6.73 $296,705 - $631,906	-93,894 Reduced 62.76%	55,725 $352,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $774,791 - $1.18 Million	-218,251 Reduced 59.33%	149,619 $586,000
Q2 2019 Aug 14, 2019	SELL	$4.1 - $8.05 $40,385 - $79,292	-9,850 Reduced 2.61%	367,870 $1.78 Million
Q1 2019 May 14, 2019	SELL	$5.41 - $8.73 $442,197 - $713,564	-81,737 Reduced 17.79%	377,720 $3.09 Million
Q4 2018 Feb 12, 2019	BUY	$5.39 - $9.15 $2.48 Million - $4.2 Million	459,457 New	459,457 $2.54 Million

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Old West Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Old West Investment Management, LLC with notifications on news.